百合花的总糖化物和Regaloside B:对于骨质分化,迁移和血管生成的潜在治疗剂
Guiling Chen1,2,3,4, Aoyin Liu1,2,3,4, Meixing He1,2,3,4
1The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
ACS omega
|August 4, 2025
概括
百合花的总糖化物 (TGL) 和其代谢物regaloside B增强了骨质分化,并减少了人类带衍生的介质干细胞 (hUCMSCs) 的炎症. 雷加洛化B似乎调解了TGL对hUCMSCs的治疗作用.
科学领域:
- 干细胞生物学 干细胞生物学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 炎症性微环境可能会对介酶干细胞 (MSC) 功能产生负面影响.
- 了解MSC上的天然化合物的分子机制对于治疗开发至关重要.
研究的目的:
- 为了研究从百合花 (TGL) 的总糖化物及其代谢物regaloside B对人类带衍生的介质干细胞 (hUCMSCs) 的影响.
- 评估它们对炎症条件下的骨质分化,迁移和血管生成的影响.
主要方法:
- hUCMSCs是在TNF-α和IFN-γ诱导的炎症环境中培养的.
- 流式细胞计,阿里扎林红色染色,qRT-PCR和西部斑点检测被用于分析细胞行为和分子标记.
- 使用UHPLC-LTQ-Orbitrap-MSn对大鼠血中TGL成分进行药理动力学分析.
主要成果:
- TGL抑制了炎症反应,抑制了细胞迁移,并促进了hUCMSCs的骨质分化.
- 该TGL代谢物,regaloside B,在hUCMSCs中显示出对炎症化学因子和血管因子的显著抑制作用.
- 药理动力学分析证实了regaloside B作为TGL的系统代谢物.
结论:
- 在受炎症影响的hUCMSC中,TGL及其代谢物regaloside B调节关键细胞过程.
- 雷加洛B在调解TGL对hUCMSCs的治疗作用方面发挥着重要作用.
- 这些发现表明TGL和regaloside B在再生医学中的潜在治疗应用.
更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.7K
09:34Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair
Published on: September 7, 2017
9.4K
相关概念视频
01:21Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K